COVID-19 Severity Is Associated with Differential Antibody Fc-mediated Innate Immune Functions
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Beyond neutralization, antibodies elicit several innate immune functions including complement deposition (ADCD), phagocytosis (ADCP), and cytotoxicity (ADCC). These functions can be both beneficial (by clearing pathogens) and/or detrimental (by inducing inflammation). We tested the possibility that qualitative differences in SARS-CoV-2 specific antibody-mediated innate immune functions contribute to Coronavirus disease 2019 (COVID-19) severity. We found that antibodies from hospitalized COVID-19 patients elicited higher ADCD but lower ADCP compared to antibodies from non-hospitalized COVID-19 patients. Consistently, higher ADCD was associated with higher systemic inflammation during COVID-19. Our study points to qualitative, differential features of anti-SARS-CoV-2 antibodies as potential contributors to COVID-19 severity.
Article activity feed
-
SciScore for 10.1101/2021.01.11.426209: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Ethics: All research protocols of the study were approved by the institutional review boards (IRB) at Rush University and The Wistar Institute. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable The cohort was also chosen to be 45–60% female per group. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources ADCD measurements: Purified IgG antibodies were analyzed for their ability to fix complement on target cells. Purified IgGsuggested: NoneExperimental Models: Cell Lines Sentences Resources 4 × 106 (ACE2)-CHO cells were pulsed with 20 μg biotinylated SARS-CoV-2 S1 or RBD proteins … SciScore for 10.1101/2021.01.11.426209: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Ethics: All research protocols of the study were approved by the institutional review boards (IRB) at Rush University and The Wistar Institute. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable The cohort was also chosen to be 45–60% female per group. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources ADCD measurements: Purified IgG antibodies were analyzed for their ability to fix complement on target cells. Purified IgGsuggested: NoneExperimental Models: Cell Lines Sentences Resources 4 × 106 (ACE2)-CHO cells were pulsed with 20 μg biotinylated SARS-CoV-2 S1 or RBD proteins (Acro Biosystems) for 30 min at 37°C. ACE2)-CHOsuggested: NoneA 200 μl suspension of THP-1 cells at 2.5 × 105 cells/ml was added to each well, for a total of 5 × 104 THP-1 cells per well. THP-1suggested: NoneSoftware and Algorithms Sentences Resources Cells were analyzed by flow cytometry, and data collected were analyzed in FlowJo software. FlowJosuggested: (FlowJo, RRID:SCR_008520)Statistical analyses were performed in Prism 7.0 (GraphPad). Prismsuggested: (PRISM, RRID:SCR_005375)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
